Ascendis Pharma A (ASND) Long-Term Debt Repayments (2023 - 2025)
Historic Long-Term Debt Repayments for Ascendis Pharma A (ASND) over the last 6 years, with Q3 2025 value amounting to -$7.7 million.
- Ascendis Pharma A's Long-Term Debt Repayments fell 14874.93% to -$7.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$20.3 million, marking a year-over-year decrease of 6757.58%. This contributed to the annual value of -$12.3 million for FY2024, which is 952.85% down from last year.
- Latest data reveals that Ascendis Pharma A reported Long-Term Debt Repayments of -$7.7 million as of Q3 2025, which was down 14874.93% from -$6.2 million recorded in Q2 2025.
- Over the past 5 years, Ascendis Pharma A's Long-Term Debt Repayments peaked at -$2.4 million during Q1 2021, and registered a low of -$7.7 million during Q3 2025.
- Its 4-year average for Long-Term Debt Repayments is -$3.6 million, with a median of -$3.0 million in 2024.
- Data for Ascendis Pharma A's Long-Term Debt Repayments shows a peak YoY increase of 655.76% (in 2025) and a maximum YoY decrease of 14874.93% (in 2025) over the last 5 years.
- Quarter analysis of 4 years shows Ascendis Pharma A's Long-Term Debt Repayments stood at -$2.4 million in 2021, then decreased by 24.34% to -$2.9 million in 2023, then decreased by 7.02% to -$3.1 million in 2024, then crashed by 143.93% to -$7.7 million in 2025.
- Its last three reported values are -$7.7 million in Q3 2025, -$6.2 million for Q2 2025, and -$3.2 million during Q1 2025.